[Abstract Only] Study: Metformin Use Linked to Reduced Risk for Cardiovascular Death and All-cause Mortality

Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial – Circulation (link to abstract – $ for full-text)

Commentaries: Metformin Use and CV Outcomes Among Diabetes Patients – American College of Cardiology (free) AND Support for metformin cardioprotective effect – Medicine Matters (free) AND Metformin Use Associated With Lower Death Risk in Type 2 Diabetes – Renal & Urology News (free)

Related: Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis – Cardiovascular Diabetology (free)